GOLPH3 and non-small cell lung carcinoma: Seven studies 11, 16, 24, 25, 27-29 revealed the correlation between the expression level of GOLPH3 and different status of lymph node metastasis in patients with NSCLC, including 354 cases with lymphatic metastasis and 531 cases without lymphatic metastasis (Table 2).